Susquehanna International »

Cytomed Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Cytomed Therapeutics (GDTC) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Cytomed Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomed Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomed Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-12-31 $40k 30k 1.33

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
Broadcom (AVGO)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Susquehanna International

Top funds holding Cytomed Therapeutics

Susquehanna International
UBS Group
Advisor Group Holdings

View all funds holding Cytomed Therapeutics